secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2022-04-04T23:59:59+00:00
Accession:  0001493152-22-009051
Event type: debt
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic issues $0.25M convertible note to Fourth Man, LLC at 12% interest
---------------------------------------------------------------------------

- Convertible promissory note principal $0.25M, 12% annual interest, matures in one year.
- Conversion price fixed at $0.10 per share; also issued 1,250,000 warrants at $0.20 exercise.
- Finder's fee to JH Darbie: 10% of gross proceeds plus warrants equal to 10% of amount raised.
- Proceeds for general working capital and repayment of certain debt; same terms as November 2021 issuances.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315222009051/0001493152-22-009051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315222009051/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-009051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer